Action 688606 HANGZHOU ALLTEST BIOTECH CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Hangzhou Alltest Biotech Co., Ltd.

Actions

688606

CNE1000053G6

Cours en clôture Shanghai S.E.
Autres places de cotation
 00:00:00 07/06/2024 		Varia. 5j. Varia. 1 janv.
51,76 CNY -0,08 % Graphique intraday de Hangzhou Alltest Biotech Co., Ltd. -10,36 % -24,55 %
29/04 Les actions chinoises et hongkongaises en hausse, tirées par les actions immobilières RE
26/04 Hangzhou Alltest Biotech Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
China, HK stocks rise, led by property shares
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback Plan announced on August 17, 2023.
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback announced on August 17, 2023, has closed with 1,030,000 shares, representing 1.32% for CNY 59.58 million.
Hangzhou Alltest Biotech Co., Ltd. agreed to acquire an unknown stake in Hangzhou Weisibo Medical Technology Co., Ltd.
Tranche Update on Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback Plan announced on August 17, 2023.
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tranche Update on Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback Plan announced on August 17, 2023.
Hangzhou Alltest Biotech Co., Ltd.(XSSC:688606) added to S&P Global BMI Index
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Hangzhou Alltest Biotech Co., Ltd. announces an Equity Buyback for CNY 60 million worth of its shares.
Hangzhou Alltest Biotech Co., Ltd. authorizes a Buyback Plan.
Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback announced on July 22, 2022, has expired.
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Hangzhou Tongzhou Biotechnology Co., Ltd. announced that it expects to receive CNY 19 million in funding from Hangzhou Alltest Biotech Co., Ltd.
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Atomo Diagnostics Limited Signs Agreement with Hangzhou Alltest Biotech Co., Ltd, for Supply of A Covid-19 1 Rapid Antigen Self-Test in the Australian and New Zealand Markets
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 688606
  4. Actualités Hangzhou Alltest Biotech Co., Ltd.
  5. Autres langues